Back


18/07/2019
ImCheck Therapeutics appoints Paul Frohna MD, PhD, PharmD, as Chief Medical Officer
ImCheck Therapeutics, a biotech company on the cutting edge of the next wave of immunotherapies against cancer and autoimmune diseases, announced today the appointment of Paul Frohna MD, PhD, PharmD as its Chief Medical Officer, a newly created position. Dr. Frohna is a physician-scientist with over 15 years of experience in the biotech industry and with expertise in translational medicine, clinical trial design and clinical and regulatory strategy. [...]

Download the pdf file





X

X